Merck Announces Agreement to Sell Amnis(R) Flow Cytometry and Guava(R) Technologies Businesses to Luminex Corporation

Information Technology Press Releases Friday October 19, 2018 14:26
DARMSTADT, Germany--19 Oct--PRNewswire/InfoQuest
  • All associated reagents under these brands included in the deal
  • Strategic agreement allows Luminex to increase footprint in multi-billion-dollar flow cytometry market
  • Deal expected to close at end of 2018

Merck, the vibrant science and technology company, today announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for EUR62.5 million.[1] The closing of the transaction, expected by the end of 2018, is subject to customary closing conditions.

Upon completion of the transaction, Luminex will own the flow cytometry plat